Sprzedaż substancji przeciwbakteryjnych stosowanych w medycynie weterynaryjnej w krajach europejskich w 2021 r.

Abstract

In November 2022 the European Medicines Agency (EMA) published the 12th report on sales of antimicrobial agents used in veterinary medicine in 31 European countries in year 2021. A total of 5,295.8 tons of such substances were sold for animal treatment, which was less of 5.6% compared to 2020. In Poland in 2021, 778.7 tons were sold, which was 14.7% of total European consumption. Differences of sales of the various antimicrobial classes between the countries (mean 84.4 mg/population correction unit [PCU] in Europe) was observed, from 2.5 mg/PCU in Norway to 296.5 mg/PCU in Cyprus (175.5 mg/PCU in Poland). These values show European and Polish decreases of 4.6% and 12.4% between 2020 and 2021, respectively The largest proportions of the sold antimicrobials were accounted for penicillins (31.2%), tetracyclines (25.8%), sulfonamides (9.9%), and macrolides (8.5%). For the antimicrobial classes belonging to the list of critically important antimicrobials with highest priority in human medicine, namely 3rd and 4th generation of cephalosporins, fluoroquinolones, and polymyxins, the sales for food-producing animals accounted for (in mg/PCU) 0.2%, 2.4, and 2.2%, of the total sales in the 31 countries in 2021, respectively. In Poland, these percentages were 0.4%, 12.7%, and 6.1%, respectively. For the period from 2018 to 2021, an overall decline in sales (mg/PCU) of 28.7% was observed, from 118.3 mg/PCU in 2018 to 84.4 mg/PCU in 2021. During this period, sales also decreased in Poland by 6.6% in Poland.